NO963143D0 - Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne - Google Patents

Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Info

Publication number
NO963143D0
NO963143D0 NO963143A NO963143A NO963143D0 NO 963143 D0 NO963143 D0 NO 963143D0 NO 963143 A NO963143 A NO 963143A NO 963143 A NO963143 A NO 963143A NO 963143 D0 NO963143 D0 NO 963143D0
Authority
NO
Norway
Prior art keywords
pct
active substances
colestipol
carries
preparation
Prior art date
Application number
NO963143A
Other languages
English (en)
Other versions
NO963143L (no
Inventor
Walter Muller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO963143D0 publication Critical patent/NO963143D0/no
Publication of NO963143L publication Critical patent/NO963143L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO963143A 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne NO963143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
PCT/EP1994/004082 WO1995020394A1 (de) 1994-01-27 1994-12-08 Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO963143D0 true NO963143D0 (no) 1996-07-26
NO963143L NO963143L (no) 1996-09-24

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963143A NO963143L (no) 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Country Status (22)

Country Link
US (1) US5858344A (no)
EP (1) EP0741574B1 (no)
JP (1) JP3701971B2 (no)
KR (1) KR100439311B1 (no)
AT (1) ATE218371T1 (no)
AU (1) AU697353B2 (no)
CA (1) CA2182417C (no)
CZ (1) CZ291006B6 (no)
DE (2) DE4402379C2 (no)
DK (1) DK0741574T3 (no)
ES (1) ES2177622T3 (no)
FI (1) FI116880B (no)
HU (1) HU223317B1 (no)
IL (1) IL112435A (no)
MY (1) MY113340A (no)
NO (1) NO963143L (no)
NZ (1) NZ277777A (no)
PL (1) PL315619A1 (no)
PT (1) PT741574E (no)
SK (1) SK97296A3 (no)
WO (1) WO1995020394A1 (no)
ZA (1) ZA95638B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
CN101534656B (zh) 2006-11-07 2013-05-22 宝洁公司 包含纤维的组合物及其制备和使用方法
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
KR20240016997A (ko) 2021-06-07 2024-02-06 고쿠리쯔 다이가쿠 호징 츠쿠바 다이가쿠 고분자화 발프로산 및 그 사용

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
ATE22804T1 (de) * 1982-03-01 1986-11-15 Efamol Ltd Pharmazeutische zusammensetzung.
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
JPH09511488A (ja) 1997-11-18
MY113340A (en) 2002-01-31
CA2182417C (en) 2007-04-17
US5858344A (en) 1999-01-12
KR970700505A (ko) 1997-02-12
AU1312795A (en) 1995-08-15
KR100439311B1 (ko) 2005-08-17
CZ291006B6 (cs) 2002-11-13
HU223317B1 (hu) 2004-05-28
IL112435A (en) 1999-01-26
HU9602041D0 (en) 1996-09-30
CA2182417A1 (en) 1995-08-03
EP0741574B1 (de) 2002-06-05
FI116880B (fi) 2006-03-31
AU697353B2 (en) 1998-10-01
JP3701971B2 (ja) 2005-10-05
DE4402379A1 (de) 1995-08-03
FI962985A0 (fi) 1996-07-26
DE4402379C2 (de) 1997-09-25
DE59410133D1 (de) 2002-07-11
CZ221396A3 (en) 1997-01-15
DK0741574T3 (da) 2002-09-23
PL315619A1 (en) 1996-11-25
IL112435A0 (en) 1995-03-30
NO963143L (no) 1996-09-24
ATE218371T1 (de) 2002-06-15
ES2177622T3 (es) 2002-12-16
HUT74434A (en) 1996-12-30
SK97296A3 (en) 1997-04-09
FI962985A (fi) 1996-07-26
NZ277777A (en) 1997-01-29
WO1995020394A1 (de) 1995-08-03
ZA95638B (en) 1995-10-25
EP0741574A1 (de) 1996-11-13
PT741574E (pt) 2002-11-29

Similar Documents

Publication Publication Date Title
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
DK0706378T3 (da) Ny farmaceutisk formulering.
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
ES2133785T3 (es) Inhibidores de metaloproteinasas.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
NO963143L (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
AU9080398A (en) Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
JO1881B1 (en) Formula II for multi unit disc calibration
ATE155136T1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JO1880B1 (en) Format 1 for multi-unit calibration discs